Alcyone Lifesciences, Inc.
Industry
- Pharmaceuticals
- Drug Delivery
- Site Specific
- Drug Delivery
- Biotechnology
Latest on Alcyone Lifesciences, Inc.
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie Taps Anima’s mRNA Platform, Immu
IN VITRO DIAGNOSTICS Mergers & Acquisitions Luminex Corp. Nanosphere Inc. Luminex Corp. is paying $77mm ($1.70 per share; a 63% premium) in cash to acquire molecular diagnostics firm Nanosphere
Start-Up Execs CRISPR Therapeutics Michael Bruce, PhD To: SVP, Program Portfolio & Alliance Mgmt. (August) From: VP, Dev. Mgmt. & Bus. Ops., Worldwide R&D, Pfizer Inc. Phone: 617-580-9212 Samar
Company Changes BUHL , Carsten To: Ambu AS , EVP, Chief Commercial Officer (August) From: GN ReSound, SVP, Europe Sales & Strategic Accounts Phone: +45 7225 2000 CARR-BRENDEL , Victoria E., Ph